LANGaware awarded Patient Engagement Solutions agreement with Premier, Inc. for Early Detection of Cognitive and Behavioral Health Diseases

LANGaware, a pioneering AI-driven healthcare technology company, has been awarded a national group purchasing agreement for Patient Engagement Solutions with Premier, Inc.

Brain Disease Research Reveals Differences Between Sexes

In APL Bioengineering, University of Maryland scientists highlight a growing body of research suggesting sex differences play roles in how patients respond to brain diseases, as well as multiple sclerosis, motor neuron disease, and other brain ailments. They are urging their colleagues to remember those differences when researching treatments and cures.

Brain’s Immune Cells Promising Cellular Target for Therapeutics

Inspired by the need for new and better therapies for neurodegenerative diseases, Rutgers University researchers are exploring the link between uncontrolled inflammation within the brain and the brain’s immune cells, known as microglia, which are emerging as a promising cellular target because of the prominent role they play in brain inflammation. In APL Bioengineering, the group highlights the design considerations and benefits of creating therapeutic nanoparticles for carrying pharmacological factors directly to the sites of the microglia.